Heron Therapeutics Inc.(HRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HRTX Heron Therapeutics Inc.

盘后交易 05-07 19:43:47 EDT

1.24

-0.07

-5.34%

盘后1.23

-0.01-0.41%

19:09 EDT

最高1.30	最低1.22	成交量134.47万
今开1.30	昨收1.31	日振幅6.11%
总市值2.34亿	流通市值1.66亿	总股本1.89亿
成交额166.87万	换手率1.00%	流通股本1.34亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HRTX","market":"US","secType":"STK","nameCN":"Heron Therapeutics Inc.","latestPrice":1.24,"timestamp":1778184000000,"preClose":1.31,"halted":0,"volume":1344704,"hourTrading":{"tag":"盘后","latestPrice":1.2349,"preClose":1.24,"latestTime":"19:09 EDT","volume":2836,"amount":3539.1640792,"timestamp":1778195370825,"change":-0.0051,"changeRate":-0.004113,"amplitude":0.030887},"delay":0,"changeRate":-0.05343511450381684,"floatShares":134000000,"shares":189000000,"eps":-0.12114,"marketStatus":"盘后交易","change":-0.07,"latestTime":"05-07 19:43:47 EDT","open":1.3,"high":1.3,"low":1.22,"amount":1668698.0575232,"amplitude":0.061069,"askPrice":1.31,"askSize":100,"bidPrice":1.12,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-0.12114,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1778198400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1390453200000,"exchange":"NASDAQ","adjPreClose":1.31,"preHourTrading":{"tag":"盘前","latestPrice":1.29,"preClose":1.31,"latestTime":"09:21 EDT","volume":4669,"amount":6036.4735284,"timestamp":1778160098959,"change":-0.02,"changeRate":-0.015267,"amplitude":0.030534},"postHourTrading":{"tag":"盘后","latestPrice":1.2349,"preClose":1.24,"latestTime":"19:09 EDT","volume":2836,"amount":3539.1640792,"timestamp":1778195370825,"change":-0.0051,"changeRate":-0.004113,"amplitude":0.030887},"volumeRatio":0.549115,"impliedVol":0.6599,"impliedVolPercentile":0.239},"requestUrl":"/m/hq/s/HRTX","defaultTab":"news","newsList":[{"id":"2602843165","title":"Heron Therapeutics, Inc.盘中异动 早盘股价大涨5.24%报1.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602843165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602843165?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:30","pubTimestamp":1767969036,"startTime":"0","endTime":"0","summary":"北京时间2026年01月09日22时30分，Heron Therapeutics, Inc.股票出现异动，股价急速上涨5.24%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Revolution Medicines Inc C/Wts 17/12/2026 、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Uniqure N.V.涨幅较大，Aptevo Therapeutics Inc.、Pmgc Holdings Inc.、Ibio, Inc.较为活跃，换手率分别为543.19%、29.03%、24.97%，振幅较大的相关个股有Allogene Therapeutics, Inc.、凯信远达、Artelo Biosciences, Inc.，振幅分别为7.25%、5.63%、5.63%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010922303797a155b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010922303797a155b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","HRTX","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176610195","title":"Heron Therapeutics公布2025年第四季度及全年初步未经审计净营收 Zynrelef®成季度增长最大驱动力","url":"https://stock-news.laohu8.com/highlight/detail?id=1176610195","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176610195?lang=zh_cn&edition=full","pubTime":"2026-01-09 22:30","pubTimestamp":1767969017,"startTime":"0","endTime":"0","summary":"Heron Therapeutics Inc. 近日披露了2025年第四季度及全年的初步未经审计净营收数据。根据初步统计，该公司在2025年第四季度实现了显著的收入增长，其中术后镇痛药物Zynrelef成为该季度业绩增长的最大贡献者。这一积极表现凸显了Zynrelef在市场中的强劲需求及其对公司整体营收的拉动作用。尽管面临市场竞争和行业挑战，Heron Therapeutics通过核心产品的商业化推进，保持了可持续的发展势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158507869","title":"Heron Therapeutics宣布Aponvie® (Aprepitant)注射乳剂纳入新发布的第五版围手术期恶心与呕吐管理共识指南","url":"https://stock-news.laohu8.com/highlight/detail?id=1158507869","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158507869?lang=zh_cn&edition=full","pubTime":"2025-12-04 21:19","pubTimestamp":1764854351,"startTime":"0","endTime":"0","summary":"Heron Therapeutics宣布Aponvie® (Aprepitant)注射乳剂纳入新发布的第五版围手术期恶心与呕吐管理共识指南。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518920577","title":"Heron Therapeutics, Inc.盘中异动 下午盘快速下跌5.02%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518920577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518920577?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:42","pubTimestamp":1741628573,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时42分，Heron Therapeutics, Inc.股票出现波动，股价急速跳水5.02%。截至发稿，该股报2.27美元/股，成交量129.027万股，换手率0.85%，振幅6.07%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5340.63%、3824.56%、989.90%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、58.34%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311014254a26a81c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311014254a26a81c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517430465","title":"Heron Therapeutics, Inc.2024财年实现净利润-13.58百万美元，同比增加87.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430465","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517430465?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363243,"startTime":"0","endTime":"0","summary":"3月8日，Heron Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-13.58百万美元，同比增加87.77%；其中营业收入为1.44亿美元，同比增加13.39%，每股基本收益为-0.09美元。从资产负债表来看，Heron Therapeutics, Inc.总负债2.67亿美元，其中短期债务3.04百万美元，资产负债比为0.88，流动比率为0.03。机构评级：截至2025年3月8日，当前有4家机构对Heron Therapeutics, Inc.目标价做出预测，其中目标均价为6.25美元，其中最低目标价为4.00美元，最高目标价为9.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000139a2647ec2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000139a2647ec2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRTX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516342886","title":"Heron Therapeutics, Inc.盘中异动 早盘股价大跌5.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516342886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516342886?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:38","pubTimestamp":1741012707,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时38分，Heron Therapeutics, Inc.股票出现波动，股价快速跳水5.67%。截至发稿，该股报2.33美元/股，成交量37.9035万股，换手率0.25%，振幅5.06%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Entero Therapeutics Inc.、Geovax Labs, Inc.、Alto Neuroscience, Inc.涨幅较大，Allarity Therapeutics, Inc.、Entero Therapeutics Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为48.65%、40.00%、31.61%，振幅较大的相关个股有Entero Therapeutics Inc.、Spruce Biosciences, Inc.、Vincerx Pharma, Inc.，振幅分别为23.25%、19.25%、18.04%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223828abe63577&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223828abe63577&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","HRTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514375311","title":"Heron Therapeutics, Inc.盘中异动 股价大涨5.12%报2.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514375311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514375311?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:18","pubTimestamp":1740755904,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时18分，Heron Therapeutics, Inc.股票出现异动，股价快速上涨5.12%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Immunitybio, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1261.22%、401.27%、331.88%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.37%、38.73%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231824989684c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231824989684c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","HRTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514438556","title":"Heron Therapeutics, Inc.盘中异动 急速拉升8.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514438556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514438556?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666726,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Heron Therapeutics, Inc.股票出现异动，股价快速拉升8.77%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、天演药业涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为410.42%、91.10%、50.47%，振幅较大的相关个股有天演药业、Pds Biotechnology Corporation、曼恩凯德生物医疗，振幅分别为13.13%、11.69%、10.24%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223206a2567a0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223206a2567a0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRTX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514801979","title":"Heron Therapeutics(HRTX.US)：2024年Q4财报实现营收4078.1万美元，前值为3423.3万美元，预期值为3737万美元；每股收益为0.02美元，前值为-0.07美元，预期值为-0.03美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514801979","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514801979?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:51","pubTimestamp":1740660669,"startTime":"0","endTime":"0","summary":"Heron Therapeutics(HRTX.US)：2024年Q4财报实现营收4078.1万美元，前值为3423.3万美元，预期值为3737万美元；每股收益为0.02美元，前值为-0.07美元，预期值为-0.03美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/27205148437296.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["HRTX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176545575","title":"Heron Therapeutics预期2025年销售额为1.53亿至1.63亿美元，对比预期为1.60633亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176545575","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176545575?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:50","pubTimestamp":1740660648,"startTime":"0","endTime":"0","summary":"2025年财务指引，Heron Therapeutics预计全年净收入为1.53亿至1.63亿美元。调整后的EBITDA预计将在0到800万美元之间。以上内容来自Benzinga Earnings专栏，原文如下：Financial Guidance for 2025 Item2025 Full-Year Guidance for Net Revenue and Adjusted EBITDA(in millions)Net Revenue$153.0to$163.0Adjusted EBITDA$0.0to$8.0","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132168551","title":"Heron Therapeutics 2024年第四季度GAAP每股收益$0.02超出$(0.03)预期，销售额$40.78M超过$37.37M预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1132168551","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132168551?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:50","pubTimestamp":1740660645,"startTime":"0","endTime":"0","summary":"Heron Therapeutics报告季度每股收益为$0.02，超出分析师一致预期的$，上涨166.67%。公司报告的季度销售额为$40.78M，超出分析师预期的$37.37M，增长了9.14%。相比去年同期的$34.23M，销售额增长了19.13%。以上内容来自Benzinga Earnings专栏，原文如下：Heron $Therapeutics$  reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $ by 166.67 percent. This is a 128.57 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $40.78 million which beat the analyst consensus estimate of $37.37 millio","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Heron Therapeutics 2024年第四季度GAAP每股收益$0.02超出$(0.03)预期，销售额$40.78M超过$37.37M预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514851095","title":"Heron Therapeutics, Inc.盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851095","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514851095?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:51","pubTimestamp":1740581510,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时51分，Heron Therapeutics, Inc.股票出现异动，股价大幅上涨5.36%。截至发稿，该股报1.77美元/股，成交量15.9569万股，换手率0.10%，振幅2.98%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Cns Pharmaceuticals, Inc.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为4236.29%、150.76%、127.50%，振幅较大的相关个股有Enveric Biosciences, Inc.、Humacyte Inc C/Wts 27/08/2026 、Renovaro Inc.，振幅分别为127.12%、38.41%、29.31%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225150abddf22b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225150abddf22b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRTX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514011285","title":"Heron Therapeutics, Inc.盘中异动 快速跳水5.05%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514011285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514011285?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:32","pubTimestamp":1740501153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时32分，Heron Therapeutics, Inc.股票出现波动，股价大幅跳水5.05%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1386.01%、1116.06%、913.58%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为224.93%、87.83%、66.67%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260032339892661b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260032339892661b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRTX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511696289","title":"Heron Therapeutics, Inc.盘中异动 急速拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511696289?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:34","pubTimestamp":1739543667,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时34分，Heron Therapeutics, Inc.股票出现波动，股价快速上涨5.45%。截至发稿，该股报1.74美元/股，成交量3.4735万股，换手率0.02%，振幅4.85%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Moleculin Biotech, Inc.、Virpax Pharmaceuticals, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为1076.96%、375.03%、345.36%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Virpax Pharmaceuticals, Inc.、Theratechnologies Inc.，振幅分别为20.20%、19.73%、18.33%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422342798858a25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422342798858a25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRTX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508680654","title":"Heron Therapeutics, Inc.盘中异动 股价大涨5.33%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508680654","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508680654?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:19","pubTimestamp":1738682399,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时19分，Heron Therapeutics, Inc.股票出现波动，股价大幅上涨5.33%。截至发稿，该股报1.78美元/股，成交量9.7861万股，换手率0.06%，振幅5.33%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.36%。其相关个股中，Azitra Inc、Evaxion Biotech As、Regulus Therapeutics Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1475.03%、871.94%、220.42%，振幅较大的相关个股有Azitra Inc、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Viracta Therapeutics, Inc.，振幅分别为64.17%、49.87%、44.22%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204231959a2393275&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204231959a2393275&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRTX","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507672472","title":"Heron Therapeutics, Inc.盘中异动 下午盘急速拉升5.39%报1.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507672472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507672472?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:24","pubTimestamp":1738265040,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时24分，Heron Therapeutics, Inc.股票出现异动，股价大幅拉升5.39%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1789.73%、305.81%、246.01%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited，振幅分别为65.98%、64.10%、61.86%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310324019876d0ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310324019876d0ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","HRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506893061","title":"Heron Therapeutics, Inc.盘中异动 急速拉升5.11%报1.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506893061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506893061?lang=zh_cn&edition=full","pubTime":"2025-01-25 01:18","pubTimestamp":1737739084,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日01时18分，Heron Therapeutics, Inc.股票出现异动，股价快速拉升5.11%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Evaxion Biotech As、Pmgc Holdings Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4028.57%、2208.09%、1634.18%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Celularity Inc C/Wts 16/07/2026 ，振幅分别为134.08%、112.09%、69.09%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125011805a22e7d76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125011805a22e7d76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HRTX","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505043910","title":"Heron Therapeutics, Inc.盘中异动 早盘股价大涨5.21%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505043910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505043910?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:16","pubTimestamp":1737648979,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时16分，Heron Therapeutics, Inc.股票出现波动，股价快速上涨5.21%。截至发稿，该股报1.72美元/股，成交量32.7628万股，换手率0.22%，振幅5.52%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Exicure, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3537.07%、1536.40%、650.36%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Jupiter Neurosciences, Inc.，振幅分别为186.07%、64.29%、55.57%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001619a22d1ffe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124001619a22d1ffe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","HRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504164750","title":"Heron Therapeutics, Inc.盘中异动 早盘快速拉升5.10%报1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504164750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504164750?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:36","pubTimestamp":1737124619,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日22时36分，Heron Therapeutics, Inc.股票出现异动，股价大幅拉升5.10%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Revolution Medicines Inc C/Wts 17/12/2026 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Aditxt, Inc.、Aeon Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为101.03%、15.66%、8.61%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Psyence Biomedical Ltd C/Wts 25/01/2029、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为44.21%、31.14%、25.64%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223659986a1647&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117223659986a1647&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","HRTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503227684","title":"Heron Therapeutics, Inc.盘中异动 临近收盘股价大跌5.19%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503227684","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503227684?lang=zh_cn&edition=full","pubTime":"2025-01-15 04:55","pubTimestamp":1736888103,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日04时55分，Heron Therapeutics, Inc.股票出现波动，股价大幅下跌5.19%。Heron Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.16%。其相关个股中，Eterna Therapeutics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Jasper Therapeutics Inc C/Wts 24/09/2026 涨幅较大，Eterna Therapeutics Inc.、Phio Pharmaceuticals Corp.、Soligenix, Inc.较为活跃，换手率分别为1102.05%、630.51%、424.81%，振幅较大的相关个股有Eterna Therapeutics Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Matinas Biopharma Holdings, Inc.，振幅分别为170.74%、146.24%、69.81%。Heron Therapeutics, Inc.公司简介：Heron Therapeutics Inc 是一家处于商业阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115045503abab01ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115045503abab01ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","HRTX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.herontx.com","stockEarnings":[{"period":"1week","weight":0.1008},{"period":"1month","weight":0.6163},{"period":"3month","weight":0.0826},{"period":"6month","weight":0.1909},{"period":"1year","weight":-0.4587},{"period":"ytd","weight":0.0077}],"compareEarnings":[{"period":"1week","weight":0.0313},{"period":"1month","weight":0.1137},{"period":"3month","weight":0.083},{"period":"6month","weight":0.0937},{"period":"1year","weight":0.3132},{"period":"ytd","weight":0.0761}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Heron Therapeutics, Inc.于1983年2月在加利福尼亚州成立，并于1987年在特拉华州重新注册。该公司是一家商业化阶段的生物技术公司，致力于为急症护理和肿瘤患者开发和商业化治疗创新产品。其急症护理产品组合包括用于术后疼痛的双效局部麻醉剂ZYNRELEF，以及用于术后恶心呕吐的静脉注射制剂APONVIE。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.007247},{"month":2,"riseRate":0.461538,"avgChangeRate":0.050706},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.060836},{"month":4,"riseRate":0.615385,"avgChangeRate":0.065319},{"month":5,"riseRate":0.384615,"avgChangeRate":0.020024},{"month":6,"riseRate":0.666667,"avgChangeRate":0.054669},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.02215},{"month":8,"riseRate":0.583333,"avgChangeRate":0.018359},{"month":9,"riseRate":0.25,"avgChangeRate":-0.098063},{"month":10,"riseRate":0.416667,"avgChangeRate":-0.043598},{"month":11,"riseRate":0.583333,"avgChangeRate":0.052026},{"month":12,"riseRate":0.5,"avgChangeRate":0.066572}],"exchange":"NASDAQ","name":"Heron Therapeutics Inc.","nameEN":"Heron Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Heron Therapeutics Inc.(HRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Heron Therapeutics Inc.(HRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Heron Therapeutics Inc.,HRTX,Heron Therapeutics Inc.股票,Heron Therapeutics Inc.股票老虎,Heron Therapeutics Inc.股票老虎国际,Heron Therapeutics Inc.行情,Heron Therapeutics Inc.股票行情,Heron Therapeutics Inc.股价,Heron Therapeutics Inc.股市,Heron Therapeutics Inc.股票价格,Heron Therapeutics Inc.股票交易,Heron Therapeutics Inc.股票购买,Heron Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Heron Therapeutics Inc.(HRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Heron Therapeutics Inc.(HRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}